Targeting Asexual and Sexual Blood Stages of the Human Malaria ParasiteP. falciparumwith 7‐Chloroquinoline‐Based 1,2,3‐Triazoles-Reference-Cited by-同舟云学术

Targeting Asexual and Sexual Blood Stages of the Human Malaria ParasiteP. falciparumwith 7‐Chloroquinoline‐Based 1,2,3‐Triazoles

Published:2019-01-29 Issue:4 Volume:14 Page:484-493
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Wadi Ishan¹^ORCID,Prasad Davinder¹,Batra Neha¹,Srivastava Kumkum²,Anvikar Anupkumar R.³,Valecha Neena³,Nath Mahendra¹^ORCID

Affiliation:

1. Department of ChemistryUniversity of Delhi Delhi 110007 India

2. Parasitology DivisionCentral Drug Research Institute, Lucknow 226031 Uttar Pradesh India

3. ICMR—National Institute of Malaria Research, Dwarka New Delhi 110077 India

Funder

University of Delhi, Delhi, India

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.201800728

Reference41 articles.

1. World Malaria Report 2016 World Health Organization Geneva 2016 License: CC-BY-NC-SA 3.0 IGO;https://www.who.int/malaria/publications/world-malaria-report-2016/report/en/(last accessed January 21 2019).

2. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study

3. 2. Policy brief on single-dose primaquine as a gametocytocide inPlasmodium falciparummalaria World Health Organization Geneva 2015 https://www.who.int/malaria/publications/atoz/policy-brief-single-dose-primaquine-pf/en/(accessed March 26 2017

4. 3. last accessed January 21 2019).

5. Critical examination of approaches exploited to assess the effectiveness of transmission-blocking drugs for malaria

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological evaluation of novel side chain containing CQTrICh-analogs as antimalarials and their development as PfCDPK1 kinase inhibitors;Heliyon;2024-02

2. Exploring diverse frontiers: Advancements of bioactive 4-aminoquinoline-based molecular hybrids in targeted therapeutics and beyond;European Journal of Medicinal Chemistry;2024-01

3. Triazole hybrid compounds: A new frontier in malaria treatment;European Journal of Medicinal Chemistry;2023-11

4. Current development of 1,2,3-triazole derived potential antimalarial scaffolds: Structure- activity relationship (SAR) and bioactive compounds;European Journal of Medicinal Chemistry;2023-11

5. Recent developments in the synthesis of hybrid antimalarial drug discovery;Bioorganic Chemistry;2023-10